RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-7.28%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.1B
AUM Growth
+$2.1B
(-19%)
Cap. Flow
-$445M
Cap. Flow
% of AUM
-21.18%
Top 10 Holdings %
Top 10 Hldgs %
55.38%
Holding
76
New
4
Increased
13
Reduced
27
Closed
8
Top Buys
| 1 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$41.2M |
| 2 |
Boston Scientific
BSX
|
$20.2M |
| 3 |
Biohaven
BHVN
|
$13.5M |
| 4 |
Regenxbio
RGNX
|
$9.01M |
| 5 |
Evolent Health
EVH
|
$6.86M |
Top Sells
| 1 |
Krystal Biotech
KRYS
|
$65.3M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$42.4M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$42.4M |
| 4 |
Amicus Therapeutics
FOLD
|
$31.9M |
| 5 |
Immunovant
IMVT
|
$31.4M |
Sector Composition
| 1 | Healthcare | 96.1% |
| 2 | Industrials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-489,208
| Closed | -$42.4M |
|